TSAP (Boltz-2)TSAP (AI-QSAR)
Oncology

TNKS2 activity model

TNKS2 (tankyrase-2) is a PARP-family enzyme that tags Axin for degradation and so tunes Wnt/β-catenin signaling. Its inhibitors stabilize Axin and are studied in Wnt-driven cancers such as colorectal cancer.

A model trained on measured activity data for TNKS2 (Oncology). Give it compounds and it predicts their IC50 against TNKS2, so you can rank candidates by it.

Predict with this model

Model card
UniProt
Q9H2K2
Reference structure
PDB 4HKI, ligand FLN
Training data
TSAP (Boltz-2): 61 compounds, IC50TSAP (AI-QSAR): 60 compounds, IC50
Validation
Predicted and measured values are compared on compounds held out of training.
Cost
From 100 cr, quoted before you submit
Model version
TSAP (Boltz-2): TSAP pipeline v2.2TSAP (AI-QSAR): Ridge regression on docking features
TNKS2 receptor structure (PDB 4HKI) with the ligand FLN in the binding pocket

Validation results

Predicted and measured values compared on compounds held out of training. RMSE is in log units (pIC50 and similar).

TSAP (Boltz-2)

Pearson r

0.83

R²

0.54

RMSE (log units)

0.59

Holdout compounds

15

TSAP (AI-QSAR)

Pearson r

0.85

Square root of RSQ

RSQ

0.72

Holdout compounds

15

How to use it

  1. Under Predict with this model, press TSAP (Boltz-2) or TSAP (AI-QSAR). The wizard of the workflow you pressed opens with the TNKS2 model already selected.

  2. Upload the SMILES of the compounds to predict as a .smi, .csv or .txt file.

  3. Check the estimated credits and time, then submit.

  4. The result is a table of compounds ranked by predicted IC50.

Limitations

  • Predictions can be less accurate for compounds whose structures differ a lot from the training data.
  • Validation used only about 15 compounds, so performance on new compounds can differ from these metrics.
  • Predictions do not replace experiments. Use them to decide what to synthesize and measure first.